Long-term support with an ambulatory percutaneous paracorporeal artificial lung
The Journal of Heart and Lung Transplantation, 05/25/2012Zhou X et al.
Authors successfully established long–term ambulatory PAL for up to 24 days using the patented DLC through a single–site percutaneous venous cannulation. Critical bleeding/thrombosis formation and gas exchanger durability remain two major challenges for long–term–ambulatory PAL.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.